| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2008;51:995.)
© 2008 American Heart Association, Inc.
Go Red Editorial Commentaries |
From the Departments of Internal Medicine and Pharmacology, Division of Cardiovascular Diseases, Cardiovascular Center, University of Iowa Carver College of Medicine, Iowa City.
Correspondence to Frank M. Faraci, Department of Internal Medicine, Division of Cardiovascular Diseases, E315-GH, University of Iowa, Carver College of Medicine, Iowa City, IA 52242-1081. E-mail frank-faraci{at}uiowa.edu
Diverse structural and functional changes occur within blood vessels during hypertension. In relation to vascular structure, hypertension is generally associated with hypertrophy (increased cross-sectional area of the vessel wall) in aorta and other large arteries but inward remodeling (with or without increases in the cross-sectional area) in smaller resistance vessels. Inward vascular remodeling, which represents a rearrangement of the vessel wall around a smaller lumen (Figure), has been described in models of hypertension in brain1 and other vascular beds.2,3 Similar changes occur in humans with hypertension, where inward remodeling is emerging as a potential risk factor for cardiovascular events.4
|
Although the term "vascular remodeling" is sometimes used rather imprecisely in studies of blood vessels, experts in the field consider inward vascular remodeling to reflect reductions in vessel diameter that are present over a range of intravascular pressures and cannot be accounted for by differences in vascular tone or vascular distensibility (vascular mechanics).2,3,5 Both hypertrophy and inward remodeling may occur in blood vessels during hypertension, but the latter change likely has the greatest impact on vascular resistance and, thus, blood flow. Thus, inward remodeling may have greater functional consequences than vascular hypertrophy.1,3
In this issue of Hypertension, Cipolla et al6 describe novel observations of changes in cerebral vascular structure brought on by hypertension during pregnancy. The findings highlight the dynamic nature of vascular remodeling under these conditions. In their study, female rats were made hypertensive using the common approach of chronic treatment with an inhibitor of NO synthase (NG-nitro-L-arginine methyl ester). Administration of NG-nitro-L-arginine methyl ester increased arterial pressure and produced inward remodeling of small cerebral arteries with no change in the cross-sectional area of the vessel wall (ie, eutrophic inward remodeling; Figure). When the animals then became pregnant, the reductions in vessel diameter that had occurred during hypertension were largely reversed (Figure). Because arterial pressure was not altered by pregnancy, this important determinant of vascular structure did not appear to play a role in these changes. Previous work from this group demonstrated that pregnancy prevented changes in cerebral vascular structure in response to subsequent hypertension.7 However, these are the first findings showing that pregnancy also reverses preexisting inward vascular remodeling.
Previous studies have tested whether experimental interventions could prevent structural changes in the vasculature during hypertension. For example, treatment with a thiazide-like diuretic prevents vascular hypertrophy without preventing inward vascular remodeling in spontaneously hypertensive rats.8 These findings and others9 suggest that mechanisms that produce vascular hypertrophy differ from those that produce inward vascular remodeling. Previously, very few studies have evaluated the regression (reversibility) of inward vascular remodeling.
Many studies continue to model changes in vascular structure using aorta in vivo or aortic smooth muscle in cell culture. Although these approaches are valuable and may help to define mechanisms that contribute to vascular hypertrophy, they may not be optimal if the goal is to model the 3D rearrangement that occurs with inward remodeling in resistance vessels during hypertension. Despite the fact that inward vascular remodeling may have a greater impact on hemodynamics, few studies have examined mechanisms that produce inward remodeling during hypertension.
What mechanism(s) accounts for inward remodeling in the cerebral circulation during hypertension? Is the same mechanism involved in the regression of vascular remodeling during pregnancy? Although oxidative stress plays an important role in producing hypertrophy in cerebral arterioles, oxidative stress may not produce inward vascular remodeling.10 One mechanism that may play a key role in promoting this process involves the renin-angiotensin system. For example, hypertrophy of cerebral arterioles occurs in models of angiotensin II–dependent and angiotensin II–independent hypertension, but inward vascular remodeling occurs only with angiotensin II–dependent hypertension.9 Thus, angiotensin II may be a key determinant of inward vascular remodeling. Because vascular responses to angiotensin II are generally reduced during pregnancy,7,11 it seems possible that regression of cerebral vascular structure during pregnancy may reflect a loss or withdrawal of angiotensin II–mediated effects that promote inward vascular remodeling.
Activity of the transcription factor peroxisome proliferator-activated receptor-
(PPAR-
) may be another important determinant of vascular structure.12 Previous work suggested that pharmacological activators of PPAR-
prevent inward remodeling of small mesenteric arteries during angiotensin II–dependent hypertension.13 Mice that express a human dominant-negative mutation in PPAR-
exhibit hypertrophy and inward remodeling in cerebral arterioles, demonstrating that PPAR-
normally protects cerebral blood vessels against abnormal growth.14 Thus, changes in the activation of PPAR-
, with the subsequent reprogramming of PPAR-
target genes, are potential mediators of altered vascular growth during hypertension, pregnancy, and/or hypertension during pregnancy. With regard to hypertension, it is noteworthy that angiotensin II (the renin-angiotensin system) is a molecular target of PPAR-
.12
What are the functional implications of these changes in cerebral vascular structure during hypertension and hypertension during pregnancy? Inward vascular remodeling may potentially have both detrimental and protective effects in the cerebral circulation. Chronic hypertension impairs the dilator capacity of cerebral blood vessels and is a major risk factor for stroke but may also contribute to cognitive decline. Inward vascular remodeling increases vascular resistance (including minimal vascular resistance) and may particularly impact and limit cerebral blood flow under conditions that produce large reductions in cerebral vascular resistance (Figure 1). Increases in minimal vascular resistance would also limit blood flow to collateral dependent regions under low blood flow conditions or ischemia.
Inward vascular remodeling during hypertension may also protect the microcirculation from dysfunction and increases in permeability because of the transmission of elevated pressure (Figure 1).2,3 Such a mechanism may be particularly important in the brain to protect the blood-brain barrier and prevent formation of cerebral edema during acute hypertension or seizures. Although these structural changes may not influence resting cerebral blood flow, they would have a significant impact on local hemodynamics under conditions when vessels are markedly dilated (such as during breakthrough of autoregulation after acute hypertension).
Hypertension is a common complication of pregnancy, and pregnancy predisposes the brain to greater edema formation during acute hypertension.7 Cerebral vascular features of eclampsia are often similar to those seen in hypertensive encephalopathy and include breakthrough of autoregulation, marked cerebral vasodilation, and disruption of the blood-brain barrier.7 Seizures are a hallmark of eclampsia, and seizures produce these same physiological responses (acute hypertension and maximal cerebral vasodilation with disruption of the blood-brain barrier). Some forms of hypertension produce inward remodeling of small cerebral arteries and arterioles. By causing regression of this remodeling, pregnancy may predispose the blood-brain barrier to disruption and formation of cerebral edema during acute hypertension or seizures (Figure).
| Acknowledgments |
|---|
The work of F.M.F. is supported by National Institutes of Health grants HL-38901, NS-24621, and HL-62984, as well as a Bugher Foundation Award in Stroke from the American Heart Association (0575092N).
Disclosures
None.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2. Izzard AS, Rizzoni D, Agabiti-Rosei E, Heagerty AM. Small artery structure and hypertension: adaptive changes and target organ damage. J Hypertens. 2005; 23: 247–250.[CrossRef][Medline] [Order article via Infotrieve]
3. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension. 1993; 21: 391–397.
4. Mathiassen ON, Buus NH, Sihm I, Thybo NK, Morn B, Schroeder AP, Thygesen K, Aalkjaer C, Lederballe O, Mulvany MJ, Christensen KL. Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens. 2007; 25: 1021–1026.[Medline] [Order article via Infotrieve]
5. Mulvany MJ, Baumbach GL, Aalkjaer C, Heagerty AM, Korsgaard N, Schiffrin EL, Heistad DD. Vascular remodeling. Hypertension. 1996; 28: 505–506.[Medline] [Order article via Infotrieve]
6. Cipolla MJ, Smith J, Bishop N, Bullinger LV, Godfrey JA. Pregnancy reverses hypertensive remodeling of cerebral arteries. Hypertension. 2008; 51: 1052–1057.
7. Cipolla MJ. Cerebrovascular function in pregnancy and eclampsia. Hypertension. 2007; 50: 14–24.
8. Chillon JM, Baumbach GL. Effects of indapamide, a thiazide-like diuretic, on structure of cerebral arterioles in hypertensive rats. Hypertension. 2004; 43: 1092–1097.
9. Baumbach GL, Sigmund CD, Faraci FM. Cerebral arteriolar structure in mice overexpressing human renin and angiotensinogen. Hypertension. 2003; 41: 50–55.
10. Baumbach GL, Didion SP, Faraci FM. Hypertrophy of cerebral arterioles in mice deficient in expression of the gene for CuZn superoxide dismutase. Stroke. 2006; 37: 1850–1855.
11. Gilbert JS, Ryan MJ, La Marca BB, Sedeek MH, Murphy SR, Granger JP. Pathophysiology of hypertension during preeclampsia: Linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2008; 294: H541–H550.
12. Schiffrin EL. Peroxisome proliferator-activated receptors and cardiovascular remodeling. Am J Physiol. 2005; 288: H1037–H1043.
13. Diep QN, El Mabrouk M, Cohn JS, Endemann D, Amiri F, Virdis A, Neves MF, Schiffrin EL. Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma. Circulation. 2002; 105: 2296–2302.
14. Halabi CM, Beyer AM, de Lange WJ, Baumbach GL, Faraci FM, Sigmund CD. Interference with PPAR-gamma function in smooth muscle causes vascular dysfunction and hypertension. Cell Metabolism. 2008; 7: 215–226.[CrossRef][Medline] [Order article via Infotrieve]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |